1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3
- 30 April 2012
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 56, S560
- https://doi.org/10.1016/s0168-8278(12)61433-0